Fiocruz International News — May 2021

Fiocruz signs agreement with Unitaid against Chagas disease

The signature of the CUIDA Chagas project to eliminate congenital disease transmission in Latin America was signed on the occasion of the World Chagas Day. The initiative, which includes co-financing from the Brazilian Ministry of Health and support from the Fiocruz Support Foundation, also involves Paraguay, Bolivia and Colombia

Fiocruz is designated as a WHO Collaborating Center to strengthen Human Milk Banks
National Institute of Women, Children and Adolescents Health Fernandes Figueira (IFF) designation will be valid for four years, starting on March 3, 2021, and can be renewed by redesignation
Article defends a new classification for COVID-19
The impact of the virus on blood coagulation might transform the disease in the first thrombotic viral fever infection. The disease is currently classified as a severe acute respiratory syndrome
COVID-19 reinfection may be accompanied by stronger symptoms
A paper published in the CDC/US journal Emerging Infectious Diseases (EID) shows that a first exposure in mild or asymptomatic cases may not produce an immune response, and that reinfection could be with the same variant
Fiocruz reinforces commitment to South-South partnership
At CDC Africa/African Union conference, Nísia Trindade Lima reaffirmed Fiocruz’ commitment to support the continent in strengthening its health systems
Fiocruz develops new vaccines to fight COVID-19
In addiction to the Oxford/AstraZeneca-Fiocruz, the Foundation is developing six other projects leading to new immunizers
Environmental vulnerability of the Amazon may contribute to new diseases
Study highlights degrading actions that the biome has been suffering is a risk to the health of populations, especially when it brings the possibility of the emergence of new diseases or the resurgence of old ones